Week of October 31, 2023 | Vol. 12, Issue 43

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Matador

Pharma | Sell-Side

Acquisition opportunity of two sterile injectable ANDAs

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pearl

Pharma | Capital Raise

Investment opportunity in late clinical-stage biopharmaceutical company

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Sterling Pharma Solutions Acquires UK Contract Research Organisation, NewChem Technologies

Sterling Pharma Solutions - Oct 13, 2023

KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma

Business Wire - Oct 16, 2023

The Road Ahead for CDMOs in 2024

Contract Pharma - Oct 23, 2023

Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companies

PR Newswire - Oct 23, 2023

Veristat acquires biometrics CRO Instat Clinical for undisclosed price

Fierce Biotech - Oct 24, 2023

OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product Français

PR Newswire - Oct 24, 2023

WuXi XDC, HKSTP Partner on Bioconjugate Drug Industry

Contract Pharma - Oct 24, 2023

TC BioPharm Selects Excellos as CDMO in Anticipation of Expanded US Clinical Trial Requirements

PR Newswire - Oct 25, 2023

AGC Biologics Signs TCR-T Cell Services Agreement to Support Medigene’s New Cell Therapy Product

Business Wire - Oct 25, 2023

Lupus Therapeutics, AbbVie partner for phase 3 trials of upadacitinib in SLE

Fierce Biotech - Oct 26, 2023

Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

PR Newswire - Oct 26, 2023

RLS Expands by Offering Radiopharmaceutical Contract Development and Manufacturing (rCDMO) Services

Business Wire - Oct 26, 2023

TANNER NEWS

World Orphan Drug Congress

✈️ Our team is on the move and heading to World Orphan Drug Congress Europe. Meet us at the largest and most established orphan drugs & rare diseases meeting to discuss how we can work together to increase patient access.